๐๐ฎ๐ก๐๐จ ๐ฃ๐จ๐ข๐ง๐ฌ ๐ญ๐ก๐ ๐๐๐๐๐๐-๐๐ ๐๐๐ง-๐๐ฎ๐ซ๐จ๐ฉ๐๐๐ง ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซโ๐ฌ ๐๐ข๐ฌ๐ฌ๐ข๐จ๐ง
The statistics are sobering but the human reality behind them is even harder.
Across Europe, countless families face agonising delays in receiving anย ๐จ๐๐๐๐๐๐๐๐โ๐ ๐
๐๐๐๐๐๐๐๐. Every lost month limits access to vital treatment, support, and care when itโs needed most.๐ง
With almostย 10 million peopleย currently living with dementia in Europe,ย a number set toย double by 2050,ย the urgency for action has never been greater.
๐๐ก๐๐ญ ๐๐๐ญ๐ข๐จ๐ง ๐ข๐ฌ ๐ง๐จ๐ฐ ๐ญ๐๐ค๐ข๐ง๐ ๐ฌ๐ก๐๐ฉ๐
We're thrilledย toย announceย that Muhdo Health has joined ACCESS-AD, a groundbreaking pan-European initiative dedicated to bringing Alzheimerโs innovations into everyday clinical practice.
๐๐๐๐๐๐-๐๐ย aims to accelerate early diagnosis and ensure equitable access to disease-modifying therapies across healthcare systems.
๐๐ฎ๐ก๐๐จโ๐ฌ ๐๐จ๐ฅ๐: ๐๐ก๐ ๐๐จ๐ฐ๐๐ซ ๐จ๐ ๐๐ฉ๐ข๐ ๐๐ง๐๐ญ๐ข๐๐ฌ ๐งฌ
Weโreย incrediblyย proud to be named theย officialย ๐๐ฉ๐ข๐ ๐๐ง๐๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ญ๐ง๐๐ซย for this consortium.
Whileย Genetics is the blueprint weโre born with,ย ๐๐ฉ๐ข๐ ๐๐ง๐๐ญ๐ข๐๐ฌย is the foreman directing construction,ย instructing our genes when to switch on or off.
Our focus,ย ๐๐๐ ๐๐๐ญ๐ก๐ฒ๐ฅ๐๐ญ๐ข๐จ๐ง, acts like dimmer switches on your DNA. Long before memory loss appears, Alzheimerโs begins subtly altering these methylation patterns.
By analysing these microscopic chemical changes, epigenetics enablesย ultra-early detection, revealing whatโs happening deep within cellsย (cellular level)ย long before symptoms surface.
๐๐ก๐ ๐
๐ฎ๐ญ๐ฎ๐ซ๐ ๐ข๐ฌ ๐๐๐ซ๐ฅ๐ฒ ๐๐ง๐ญ๐๐ซ๐ฏ๐๐ง๐ญ๐ข๐จ๐ง
Detecting these changes early unlocks everything that follows.
The work weโre undertaking withย ๐๐๐๐๐๐-๐๐ย isnโt just about better diagnostics,ย itโs about building the foundation for proactive therapies andย ultimately, true, genuineย prevention.
Weโre honoured to bring our science and technology to this critical mission, alongside our partners and the Innovative Health Initiative (IHI)
